ConductScience.org, home

Paper39367409

Pharmacological targeting of P300/CBP reveals EWS::FLI1-mediated senescence evasion in Ewing sarcoma.

Wei E and 9 others. Mol Cancer, 2024. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Pharmacological targeting of P300/CBP reveals EWS::FLI1-mediated senescence evasion in Ewing sarcoma. Papers, record 39367409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39367409

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacological targeting of P300/CBP reveals EWS::FLI1-mediated senescence evasion in Ewing sarcoma.
PubMed
Journal
Mol Cancer
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
1.81, provisional
iCite
Revised in PubMed
2026-09-22
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wei EErdong
2Mitanoska AAna
3O'Brien QQuinn
4Porter KKendall
5Molina MMacKenzie
6Ahsan HHaseeb
7Jung UUsuk
8Mills LLauren
9Kyba MMichael
10Bosnakovski DDarko

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cellular SenescenceMajor topic
Oncogene Proteins, FusionMajor topic
p300-CBP Transcription FactorsMajor topic
Proto-Oncogene Protein c-fli-1Major topic
RNA-Binding Protein EWSMajor topic
Sarcoma, EwingMajor topic
Humans
Cell Line, Tumor
Gene Expression Regulation, Neoplastic
Mesenchymal Stem Cells
Signal Transduction
E1A-Associated p300 Protein

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
HT9425-23-1-0456Department of DefensePubMed

Source PubMed

Download CSV of grants

References70

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
128710342Vincristine, Ifosfamide, and Doxorubicin for Initial Treatment of Ewing Sarcoma in Adults.Oncologist2017https://conductscience.org/library/papers/28710342PubMed
236117234Pharmacological targeting of CBP/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cells.Cancer Gene Ther2023https://conductscience.org/library/papers/36117234PubMed
325453903EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma.Cancer Cell2014https://conductscience.org/library/papers/25453903PubMed
434642317Inactivation of the CIC-DUX4 oncogene through P300/CBP inhibition, a therapeutic approach for CIC-DUX4 sarcoma.Oncogenesis2021https://conductscience.org/library/papers/34642317PubMed
537848888Engineering siRNA therapeutics: challenges and strategies.J Nanobiotechnology2023https://conductscience.org/library/papers/37848888PubMed
632371576Combined Targeting of the BRD4-NUT-p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734.Mol Cancer Ther2020https://conductscience.org/library/papers/32371576PubMed
735252191Why Senescent Cells Are Resistant to Apoptosis: An Insight for Senolytic Development.Front Cell Dev Biol2022https://conductscience.org/library/papers/35252191PubMed
833497548Ewing's Sarcoma.N Engl J Med2021https://conductscience.org/library/papers/33497548PubMed
916921403Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all.Nat Rev Mol Cell Biol2006https://conductscience.org/library/papers/16921403PubMed
1035950293A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.Cancer Med2023https://conductscience.org/library/papers/35950293PubMed
1127109631Three-year Follow up of GMCSF/bi-shRNA(furin) DNA-transfected Autologous Tumor Immunotherapy (Vigil) in Metastatic Advanced Ewing's Sarcoma.Mol Ther2016https://conductscience.org/library/papers/27109631PubMed
1211591713Dual role of p300 in the regulation of p53 stability.J Biol Chem2001https://conductscience.org/library/papers/11591713PubMed
1312086853The Ewing's sarcoma oncoprotein EWS/FLI induces a p53-dependent growth arrest in primary human fibroblasts.Cancer Cell2002https://conductscience.org/library/papers/12086853PubMed
1420547982Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.J Clin Oncol2010https://conductscience.org/library/papers/20547982PubMed
1535836809Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents.Theranostics2022https://conductscience.org/library/papers/35836809PubMed
1633850273P300/CBP inhibition sensitizes mantle cell lymphoma to PI3Kδ inhibitor idelalisib.Acta Pharmacol Sin2022https://conductscience.org/library/papers/33850273PubMed
1729382926Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99.Oncogene2018https://conductscience.org/library/papers/29382926PubMed
1826951377DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes.Nucleic Acids Res2016https://conductscience.org/library/papers/26951377PubMed
1920808728Regularization Paths for Generalized Linear Models via Coordinate Descent.J Stat Softw2010https://conductscience.org/library/papers/20808728PubMed
2032366905Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma.Oncogene2020https://conductscience.org/library/papers/32366905PubMed

See all 70 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
42643391Aging-associated immune and stromal programs mark interferon- and remodeling-linked spatial contexts in psoriatic skin.Front Immunol2026https://conductscience.org/library/papers/42643391PubMed
42464641From cell to disease: Regulatory networks and mechanisms of super‑enhancers in aging (Review).Mol Med Rep2026https://conductscience.org/library/papers/42464641PubMed
41957177Targeted and molecular therapies in Ewing sarcoma: a comprehensive review of preclinical and clinical advances.Clin Transl Oncol2026https://conductscience.org/library/papers/41957177PubMed
41889820An epigenetic bifunctional that toggles between transactivation and repression.bioRxiv2026https://conductscience.org/library/papers/41889820PubMed
41676338RNA-based therapies for colorectal cancer: targeting the β-catenin pathway via microbiota -modulated miRNAs.Front Mol Biosci2025https://conductscience.org/library/papers/41676338PubMed
41659547BAF complex-independent gene activation by SS18::SSX.bioRxiv2026https://conductscience.org/library/papers/41659547PubMed
41594575Heterogeneous Folding Intermediates Govern the Conformational Pathway of the RNA Recognition Motif Domain of the Ewing Sarcoma Protein.Biomolecules2025https://conductscience.org/library/papers/41594575PubMed
41299516Modeling CIC::DUX4 sarcoma reveals oncogene-mediated MHCI-dependent immune evasion.Mol Cancer2025https://conductscience.org/library/papers/41299516PubMed
41240117Clinical characteristics and target exploration via scRNA-seq and high-throughput drug screening of FOXO1 fusion positive rhabdomyosarcoma.Pediatr Surg Int2025https://conductscience.org/library/papers/41240117PubMed
41228232Masters of Gene Expression: Transcription Factors in Pediatric Cancers.Cancers (Basel)2025https://conductscience.org/library/papers/41228232PubMed
40429954The Double Life of microRNAs in Bone Sarcomas: Oncogenic Drivers and Tumor Suppressors.Int J Mol Sci2025https://conductscience.org/library/papers/40429954PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CREBBP1387PubTator's text mininghttps://conductscience.org/library/genes/1387NCBI Gene
EP3002033PubTator's text mininghttps://conductscience.org/library/genes/2033NCBI Gene
EWSR12130PubTator's text mininghttps://conductscience.org/library/genes/2130NCBI Gene
LMNB14001PubTator's text mininghttps://conductscience.org/library/genes/4001NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39367409

GET https://conductscience.org/api/papers/v1/39367409/references?page=2